Premalignant lesions of the esophagogastric mucosa

Seminars in Oncology

Volumn 31, Issue 4, 2004, Pages 498-512

  Lambert, R ^a   Hainaut, P ^a   Parkin, D M ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIOXIDANT; OPIATE; SODIUM CHLORIDE;

ADENOCARCINOMA; ATROPHY; BARRETT ESOPHAGUS; BEVERAGE; CANCER CLASSIFICATION; CANCER GRADING; CANCER LOCALIZATION; CANCER PREVENTION; CANCER SCREENING; CANCER STAGING; CHRONIC DISEASE; CHRONIC GASTRITIS; ENDOSCOPY; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LOWER ESOPHAGUS SPHINCTER; PATHOGENICITY; PRECANCER; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; STANDARDIZATION; STOMACH CARCINOMA; STOMACH EPITHELIUM; TOBACCO; TREATMENT PLANNING;

EID: 4043177651     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2004.04.017     Document Type: Article

References (87)

1. Guindi M., Riddell R.H. The pathology of epithelial premalignancy of the gastrointestinal tract. Best Pract Res Clin Gastroenterol. 15:2001;191-210
2. Jass J.R., Talbot I.C. Molecular and cellular biology of premalignancy in the gastrointestinal tract. Best Pract Res Clin Gastroenterol. 15:2001;175-189
3. Ferlay J., Bray F., Pisani P., et al. Globocan 2000. Cancer Incidence, Mortality and Prevalence Worldwide. 2001;IARC Press, Lyon, France
4. Makuuchi H. Endoscopic mucosal resection for mucosal cancer in the esophagus. Gastrointest Endosc Clin North Am. 11:2001;445-458
5. Ono H., Kondo H., Gotoda T., et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut. 48:2001;225-229
6. Lambert R. Treatment of esophagogastric tumors. Endoscopy. 35:2003;118-126
7. Shim C.S. Endoscopic mucosal resection An overview of the value of different techniques. Endoscopy. 33:2001;271-275
8. Spechler S.J. Clinical practice. Barrett's esophagus. N Engl J Med. 346:2002;836-842
9. Glickman J.N., Chen Y.Y., Wang H.H., et al. Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett's esophagus. Am J Surg Pathol. 25:2001;569-578
10. Shields H.M., Rosenberg S.J., Zwas F.R., et al. Prospective evaluation of multilayered epithelium in Barrett's esophagus. Am J Gastroenterol. 96:2001;3268-3273
11. Zhang Z., Yuan Y., Gao H., et al. Apoptosis, proliferation and p53 gene expression of H. pylori associated gastric epithelial lesions. World J Gastroenterol. 7:2001;779-782
12. Petersson F., Borch K., Franzen L.E. Gastric epithelial proliferation and p53 and p21 expression in a general population sample relations to age, sex, and mucosal changes associated with H. pylori infection. Dig Dis Sci. 47:2002;1558-1566
13. Wang J., Chi D.S., Kalin G.B., et al. Helicobacter pylori infection and oncogene expressions in gastric carcinoma and its precursor lesions. Dig Dis Sci. 47:2002;107-113
14. Wambura C., Aoyama N., Shirasaka D., et al. Effect of Helicobacter pylori-induced cyclooxygenase-2 on gastric epithelial cell kinetics Implication for gastric carcinogenesis. Helicobacter. 7:2002;129-138
15. Yang A., Schweitzer R., Sun D., et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 398:1999;714-718
16. DeLaurenzi V., Rossi A., Terrinoni A., et al. p63 and p73 transactivate differentiation gene promoters in human keratinocytes. Biochem Biophys Res Commun. 273:2000;342-346
17. Hainaut P., Hollstein M. p53 and human cancer The first ten thousand mutations. Adv Cancer Res. 77:2000;81-137
18. Si H.X., Tsao S.W., Poon C.S., et al. Viral load of HPV in esophageal squamous cell carcinoma. Int J Cancer. 103:2003;496-500
19. Yokoyama A., Omori T. Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers. Jpn J Clin Oncol. 33:2003;111-121
20. Tanière P., Martel-Planche G., Maurici D., et al. Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia. Am J Pathol. 158:2001;33-40
21. Zhang Z.F., Kurtz R.C., Klimstra D.S., et al. Helicobacter pylori infection and the risk of stomach cancer and chronic atrophic gastritis. Cancer Detect Prev. 23:1999;357-367
22. Blaser M.J., Berg D.E. Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest. 107:2001;767-773
23. Parkin D.M., Ferlay J., Hamdi Cherif M., et al. Cancer in Africa. Epidemiology and Prevention. 2003;IARC Press, Lyon, France
24. Campbell D.I., Warren B.F., Thomas J.E., et al. The African enigma Low prevalence of gastric atrophy, high prevalence of chronic inflammation in West African Adults and children. Helicobacter. 6:2001;263-267
25. Danesh J. Helicobacter pylori infection and gastric cancer Systematic review of the epidemiological studies. Aliment Pharmacol Ther. 13:1999;851-856
26. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori A combined analysis of 12 case-control studies nested within prospective cohorts. Gut. 49:2001;347-353
27. Wu A.H., Crabtree J.E., Bernstein L., et al. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer. 103:2003;815-821
28. Rugge M., Correa P., Dixon M.F., et al. Gastric dysplasia; the Padova international classification. Am J Surg Pathol. 254:2000;167-176
29. Schlemper R.J., Riddell R.H., Kato Y., et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 47:2000;251-255
30. Dixon M.F. Gastrointestinal epithelial neoplasia Vienna revisited. Gut. 51:2002;130-131
31. Gao H., Wang L.D., Zhou Q., et al. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res. 54:1994;4342-4346
32. Couvelard A., Cauvin J.M., Goldfain D., et al. Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology. Gut. 49:2001;761-766
33. Odze R. Cytokeratin 7/20 immunostaining Barrett's oesophagus or gastric intestinal metaplasia? Lancet. 359:2002;1711-1713
34. Shen B., Ormsby A.H., Shen C., et al. Cytokeratin expression patterns in noncardia, intestinal metaplasia-associated gastric adenocarcinoma Implication for the evaluation of intestinal metaplasia and tumors at the esophagogastric junction. Cancer. 94:2002;820-831
35. Tanière P., Borghi-Scoazec G., Saurin J.C., et al. Cytokeratin expression in adenocarcinomas of the esophagogastric junction A comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach. Am J Surg Pathol. 26:2002;1213-1221
36. Wu T.T., Watanabe T., Heitmiller R., et al. Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Am J Pathol. 153:1998;287-294
37. Montesano R., Hainaut P. Molecular precursor lesions in oesophageal cancer. Cancer Surv. 32:1998;53-68
38. El-Rifai W., Frierson H.F. Jr, Moskaluk C.A., et al. Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosa. Gastroenterology. 121:2001;592-598
39. Correa P. Human gastric carcinogenesis A multistep and multifactorial process - First American Cancer Society Award lecture on cancer epidemiology and prevention. Cancer Res. 52:1992;6735-6740
40. Lee J.H., Abraham S.C., Kim H.S., et al. Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am J Pathol. 161:2002;611-618
41. Torbenson M., Lee J.H., Cruz-Correa M., et al. Sporadic fundic gland polyposis A clinical, histological, and molecular analysis. Mod Pathol. 15:2002;718-723
42. Abraham S.C., Singh V.K., Yardley J.H., et al. Hyperplastic polyps of the stomach Associations with histologic patterns of gastritis and gastric atrophy. Am J Surg Pathol. 25:2001;500-507
43. Muehldorfer S.M., Stolte M., Martus P., et al. Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps A prospective multicentre study. Gut. 50:2002;465-470
44. Ohkusa T., Takashimizu I., Fujiki K., et al. Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial. Ann Intern Med. 129:1998;712-715
45. Abraham S.C., Park S.J., Mugartegui L., et al. Sporadic fundic gland polyps with epithelial dysplasia Evidence for preferential targeting for mutations in the adenomatous polyposis coli gene. Am J Pathol. 161:2002;1735-1742
46. Inoue H., Rey J.F., Lightdale C. Lugol chromoendoscopy for esophageal squamous cell cancer. Endoscopy. 33:2001;75-79
47. Shimizu Y., Tukagoshi H., Fujita M., et al. Endoscopic screening for early esophageal cancer by iodine staining in patients with other current or prior primary cancers. Gastrointest Endosc. 53:2001;1-5
48. Endo T., Awakawa T., Takahashi H., et al. Classification of Barrett's epithelium by magnifying endoscopy. Gastrointest Endosc. 55:2002;641-647
49. Guelrud M., Herrera I., Essenfeld H., et al. Enhanced magnification endoscopy A new technique to identify specialized intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc. 53:2001;559-565
50. Kumagai Y., Inoue H., Nagai K., et al. Magnifying endoscopy, stereoscopic microscopy, and the microvascular architecture of superficial esophageal carcinoma. Endoscopy. 34:2002;369-375
51. Sharma P., Weston A.P., Topalovski M., et al. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus. Gut. 52:2003;24-27
52. Tajiri H., Doi T., Endo H., et al. Routine endoscopy using a magnifying endoscope for gastric cancer diagnosis. Endoscopy. 34:2002;772-777
53. Yao K., Oishi T. Microgastroscopic findings of mucosal microvascular architecture as vizualized by magnifying endoscopy. Dig Endosc. 13:(suppl):2001;S27-S33
54. Lambert R., Rey J.F., Sankaranarayanan R. Magnification and chromoscopy with the acetic acid test. Endoscopy. 35:2003;437-445
55. Rollins A.M., Sivak M.V. Potential new endoscopic techniques for the earlier diagnosis of premalignancy. Best Pract Res Clin Gastroenterol. 15:2001;227-247
56. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma. 2nd English edition Gastric Cancer. 1:1998;10-24
57. Japanese Society for Esophageal Diseases. Guidelines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus. (ed 9) :1999;Kanehara, Tokyo, Japan
58. Dawsey S.M., Lewin K.J., Wang G.Q., et al. Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow up study from Linxian, China. Cancer. 74:1994;1686-1692
59. Dawsey S.M., Lewin K.J., Liu F.S., et al. Esophageal morphology from Linxian, China. Squamous histologic findings in 754 patients. Cancer. 73:1994;2027-2237
60. Qiu S.L., Yang G.R. Precursor lesions of esophageal cancer in high risk populations in Henan province, China. Cancer. 62:1988;551-557
61. Katakura T., Masuda T., Ikeda T., et al. Immunohistochemical studies in depressed type adenomas of the stomach. Comparison with protruded type adenomas and depressed type well differentiated mucosal gastric cancer. (in Japanese) Nippon Shokakibyo Gakkai Zasshi. 95:1998;992-1000
62. Xuan Z.X., Ambe K., Enjoji M. Depressed adenoma of the stomach, revisited. Histologic, histochemical and immunochemical profiles. Cancer. 67:1991;2382-2389
63. Schmitz G.M., Stolte M. Gastric polyps and precancerous lesions. Gastrointest Endosc Clin North Am. 7:1997;29-46
64. Stolte M. Clinical consequences of the endoscopic diagnosis of gastric polyps. Endoscopy. 27:1995;32-37
65. Stolte M., Sticht T., Eidt S., et al. Frequency, location, and age and sex distribution of various types of gastric polyp. Endoscopy. 26:1994;659-665
66. Stolte M. Hyperplastic polyps of the stomach Associations with histologic patterns of gastritis and gastric atrophy. Am J Surg Pathol. 25:2001;1342-1344
67. Park D.I., Rhee P.l., Kim J.E., et al. Factors suggesting malignant transformation of gastric adenoma Univariate and multivariate analysis. Endoscopy. 33:2001;501-506
68. Kodama M., Kakegawa T. Treatment of superficial cancer of the esophagus A summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery. 123:1998;432-439
69. National Report of the Group Medical Examination for Digestive Cancer in 1999. (in Japanese) J Gastroenterol Mass Sur. 40:2002;57-76
70. Hosokawa O., Tsuda S., Kidani E., et al. Diagnosis of gastric cancer up to three years after negative upper gastrointestinal endoscopy. Endoscopy. 30:1998;669-741
71. Hosokawa O., Watanabe K., Hatorri M., et al. Detection of gastric cancer by repeat endoscopy within a short time after negative examination. Endoscopy. 33:2001;301-305
72. Lambert R., Guilloux A., Oshima A., et al. Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer. 97:2002;811-818
73. Canto M.I., Setrakian S., Willis J.E., et al. Methylene blue staining of dysplastic and non dysplastic Barrett's esophagus An in vivo and ex vivo study. Endoscopy. 33:2001;391-400
74. Levine D.S., Blount P.L., Rudolph R.E., et al. Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus. Am J Gastroenterol. 95:2000;1152-1157
75. Tsukuma H., Oshima A., Narahara H., et al. Natural history of early gastric cancer A non concurrent long term follow up study. Gut. 4:2000;618-621
76. Wang G.Q., Dawsey S.M., Li J.Y., et al. Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach Results from the General Population Trial in Linxian, China. Cancer Epidemiol Biomarkers Prev. 3:1994;161-166
77. Ye W., Chow W.H., Lagergren J., et al. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology. 121:2001;1286-1293
78. Fennerty M.B., Triadafilopoulos G. Barrett's-related esophageal adenocarcinoma Is chemoprevention a potential option? Am J Gastroenterol. 96:2001;2302-2305
79. Sonnenberg A., Fennerty M.B. Medical decision analysis of chemoprevention against esophageal adenocarcinoma. Gastroenterology. 124:2003;. 1758-1756
80. Malila N., Taylor P.R., Virtanen M.J., et al. Effects of alpha-tocopherol and beta-carotene supplementation on gastric cancer incidence in male smokers (ATBC Study, Finland). Cancer Causes Control. 13:2002;617-623
81. Watanabe H., Komukai S., Ajioka Y., et al. Histopathology of m3 and sm1 invasive squamous cell carcinoma of the esophagus with special reference to endoscopic resection. (in Japanese) Stomach Intestine. 33:1998;985-992
82. May A., Gossner L., Pech O., et al. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment barrett's esophagus (SSBE) Curative treatment using local endoscopic treatment techniques. Endoscopy. 34:2002;604-610
83. Pech O., Gossner A., May A., et al. Management of Barrett's esophagus, dysplasia and early adenocarcinoma. Best Pract Res Clin Gastroenterol. 15:2001;267-284
84. Pech O., Nagy C.D., Gossner L., et al. Photodynamic therapy of human Barrett cancer using 5-aminolaevulinic acid induced protoporphyrin IX An in vivo dosimetric study in athymic nude mice. Eur J Gastroenterol Hepatol. 14:2002;657-662
85. Sonnenberg A., Soni A., Sampliner R.E. Medical decision analysis of endoscopic surveillance of Barrett's oesophagus to prevent oesophageal adenocarcinoma. Aliment Pharmacol Ther. 16:2002;41-50
86. Whithing J.L., Sigurdsson A., Rowlands D.C., et al. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut. 50:2002;378-381
87. Kokkola A., Sipponen P., Rautelin H. The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia. Aliment Pharmacol Ther. 16:2002;515-520